Sub-cutaneous insulin infusions (insulin pumps)

Answers to commonly asked questions about sub-cutaneous insulin infusions.

Questions and answers


Who may benefit from using continuous sub- cutaneous insulin infusions (insulin pumps)?

Insulin pumps may slightly improve blood glucose levels and reduce the number of severe hypoglycaemic events in people with type 1 diabetes when compared to multiple daily injections.

Are insulin pumps publicly subsidised in New Zealand?

PHARMAC funds insulin pumps and consumables for patients who meet the Special Authority criteria (SA1604 for consumables and SA1603 for pumps).

For general information regarding Special Authority see Special Authority - electronic.

What is the criteria for accessing insulin pumps?

Patients who have been diagnosed with the following conditions may be eligible for insulin pump and consumables funding if they meet the associated Special Authority criteria:

  • Type 1 diabetes
  • Permanent neonatal diabetes
  • Cystic fibrosis related diabetes
  • Undergone a pancreatectomy.

There are four categories under which a patient can be considered for funding:

  • Permanent neonatal diabetes
  • Severe unexplained hypoglycaemia
  • HbA1c
  • Previous use before 1 September 2012.
Back to top